Evidence map›Paper›PMID 37704826›Full record

ReviewActa diabetologica2024

Partial GCK gene deletion mutations causing maturity-onset diabetes of the young.

Ruiqi Yu, Haichen Zhang, Xinhua Xiao

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Acta diabetologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ruiqi YuKey Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Haichen ZhangKey Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Xinhua XiaoKey Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China. xiaoxh2014@vip.163.com.ORCID http://orcid.org/0000-0001-5441-7766
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBGI Group (China) · CN

Funding

Beijing Municipal Science and Technology Commission Z201100005520011CAMS Innovation Fund for Medical Sciences CIFMS2017-I2M-1-008CAMS Innovation Fund for Medical Sciences CIFMS2021-1-I2M-002Key Technologies Research and Development Program 2018YFC2001100National High Level Hospital Clinical Research Funding 2022-PUMCH-B-121National High Level Hospital Clinical Research Funding 2022-PUMCH-C-019National Natural Science Foundation of China 81170736National Natural Science Foundation of China 81570715National Natural Science Foundation of China 81870545National Natural Science Foundation of China 81870579National Natural Science Foundation of China 82170854Natural Science Foundation of Beijing Municipality 7202163
6 · The paper itself

Abstract

aimsMaturity-onset diabetes of the young (MODY) is an autosomal dominant monogenic form of diabetes, and glucokinase-maturity-onset diabetes of the young (GCK-MODY), or MODY 2, being the most prevalent type. However, the presence of copy number variants (CNVs) may lead to misdiagnoses, as genetic testing for MODY is typically reliant on sequencing techniques. This study aimed to describe the process of diagnosis in a Chinese pedigree with an exon 8-10 deletion of the GCK gene.

methodsThis study collected clinical data and medical history through direct interviews with the patient and reviewing relevant medical records. Sanger sequencing and whole exome sequencing (WES) were conducted over years of follow up. WES-based CNV sequencing technology was used to detect CNVs and the results were validated by multiplex ligation-dependent amplification dosage assay (MLPA). Additionally, we reviewed the previously reported cases caused by heterozygous exon deletion of the GCK gene.

resultsWES-based CNV detection revealed a heterozygous exon 8-10 deletion in the GCK gene within this particular pedigree after Sanger sequencing and WES failed to find causal variants in single nucleotide variations (SNVs) and small indels. The deletion was considered pathogenic according to ACMG/AMP and ClinGen guidelines. Most of the previously reported cases caused by heterozygous exon deletion or whole gene deletion of the GCK gene present similarly to GCK-MODY caused by SNVs and small indels.

conclusionsThis study contributed to progress in our comprehension of the mutation spectrum of the GCK gene and underscored the significance of CNV detection in the genetic testing of MODY.

Indexed as

Diabetes Mellitus, Type 2Gene DeletionGenetic TestingGlucokinaseHumansMutationGlucokinaseCopy number variationExon deletionGCK-MODYMonogenic diabetes

Identifiers

PMID37704826
OpenAlexW4386698659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.